Published in Diabet Med on May 01, 2012
Statins use is associated with poorer glycaemic control in a cohort of hypertensive patients with diabetes and without diabetes. Diabetol Metab Syndr (2014) 0.82
Do statins interfere with lifestyle intervention in the prevention of diabetes in primary healthcare? One-year follow-up of the FIN-D2D project. BMJ Open (2012) 0.81
Effect of ezetimibe on insulin secretion in db/db diabetic mice. Exp Diabetes Res (2012) 0.80
Statins impair glucose uptake in human cells. BMJ Open Diabetes Res Care (2014) 0.78
Association of statin use and hypertriglyceridemia with diabetic macular edema in patients with type 2 diabetes and diabetic retinopathy. Cardiovasc Diabetol (2017) 0.75
Do statins adversely affect the HbA1c of diabetic patients? Malays Fam Physician (2017) 0.75
Statins and glycaemic control--a cause for concern? Diabet Med (2012) 0.75
Association between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications. Drug Des Devel Ther (2015) 0.75
Elevated Basal Insulin Secretion in Type 2 Diabetes Caused by Reduced Plasma Membrane Cholesterol. Mol Endocrinol (2016) 0.75
Efficacy and safety of canagliflozin in patients with type 2 diabetes based on history of cardiovascular disease or cardiovascular risk factors: a post hoc analysis of pooled data. Cardiovasc Diabetol (2017) 0.75
Effect of high-potency statins on HbA1c in patients with or without diabetes mellitus. J Pharm Health Care Sci (2016) 0.75
[Assessment of renal function according to the NHG protocol 'Diabetes mellitus type 2': risk of overestimating the number of diabetes patients with renal dysfunction]. Ned Tijdschr Geneeskd (2007) 2.96
Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB Prospective Complications Study. Diabetologia (2005) 2.16
Early development of the metabolic syndrome after chemotherapy for testicular cancer. Ann Oncol (2012) 1.70
[The prevalence of the metabolic syndrome in the Netherlands: increased risk of cardiovascular diseases and diabetes mellitus type 2 in one quarter of persons under 60]. Ned Tijdschr Geneeskd (2007) 1.54
Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol (1999) 1.51
Time course of specific AGEs during optimised glycaemic control in type 2 diabetes. Neth J Med (2006) 1.46
Interference from heterophilic antibodies in seven current TSH assays. Ann Clin Biochem (2008) 1.42
Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial. J Intern Med (2005) 1.40
The challenge of multidisciplinary research: improving diabetic pregnancy together. Neth J Med (2013) 1.39
[Two patients with mitochondrial respiratory chain disease]. Ned Tijdschr Geneeskd (2008) 1.38
Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Blood (1995) 1.37
Cyclic Cushing's syndrome: a clinical challenge. Eur J Endocrinol (2007) 1.30
Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: roles of pre beta-HDL, phospholipid transfer protein and cholesterol esterification. Atherosclerosis (2007) 1.28
Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress. Diabetologia (2010) 1.27
Plasmalogen biosynthesis in peroxisomal disorders: fatty alcohol versus alkylglycerol precursors. J Lipid Res (1988) 1.27
Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study. Eur J Clin Invest (2009) 1.22
Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequences. Neth J Med (2013) 1.20
Development of sulfasalazine resistance in human T cells induces expression of the multidrug resistance transporter ABCG2 (BCRP) and augmented production of TNFalpha. Ann Rheum Dis (2004) 1.13
[Efficient and improved diagnosis of osteoporosis by simultaneous bone density measurement and spinal morphometry]. Ned Tijdschr Geneeskd (2008) 1.12
Intravenous pamidronate compared with oral alendronate for the treatment of postmenopausal osteoporosis. Neth J Med (2002) 1.11
Phospholipase A2 levels in acute chest syndrome of sickle cell disease. Blood (1996) 1.08
Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a). Br J Sports Med (2004) 1.08
Current therapeutic interventions in the glycation pathway: evidence from clinical studies. Diabetes Obes Metab (2013) 1.04
Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus. Diabetologia (2005) 1.04
[Tissue-specific changes in cortisol metabolism and their potential role in the metabolic syndrome]. Ned Tijdschr Geneeskd (2005) 1.04
Advanced glycation end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina. Diabetologia (2007) 1.03
Androgenic anabolic steroid use and severe hypothalamic-pituitary dysfunction: a case study. Int J Sports Med (2003) 1.01
Preoperative pharmacological management of phaeochromocytoma. Neth J Med (2006) 1.00
Resource consumption and costs in Dutch patients with type 2 diabetes mellitus. Results from 29 general practices. Diabet Med (2002) 1.00
Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial. Diabetes Obes Metab (2007) 0.98
Role of methylglyoxal adducts in the development of vascular complications in diabetes mellitus. Biochem Soc Trans (2003) 0.96
The nurse specialist as main care-provider for patients with type 2 diabetes in a primary care setting: effects on patient outcomes. Int J Nurs Stud (2002) 0.95
Combined vertebral fracture assessment and bone mineral density measurement: a new standard in the diagnosis of osteoporosis in academic populations. Osteoporos Int (2010) 0.94
Pleiotropic effects of obesity-susceptibility loci on metabolic traits: a meta-analysis of up to 37,874 individuals. Diabetologia (2013) 0.93
Determinants of HbA1c in nondiabetic Dutch adults: genetic loci and clinical and lifestyle parameters, and their interactions in the Lifelines Cohort Study. J Intern Med (2012) 0.91
Hypoglycaemia with insulin aspart: a double-blind, randomised, crossover trial in subjects with Type 1 diabetes. Diabet Med (2004) 0.91
Type 2 diabetes mellitus is associated with an imbalance in circulating endothelial and smooth muscle progenitor cell numbers. Diabetologia (2012) 0.90
Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts. Rheumatology (Oxford) (2008) 0.89
N(epsilon)-(carboxymethyl)lysine depositions in intramyocardial blood vessels in human and rat acute myocardial infarction: a predictor or reflection of infarction? Arterioscler Thromb Vasc Biol (2006) 0.87
Apolipoprotein B/A-I and total cholesterol/high-density lipoprotein cholesterol ratios both predict cardiovascular events in the general population independently of nonlipid risk factors, albuminuria and C-reactive protein. J Intern Med (2010) 0.87
Increased alpha3-fucosylation of alpha1-acid glycoprotein in Type I diabetic patients is related to vascular function. Glycoconj J (2001) 0.86
Progressive vertebral deformities despite unchanged bone mineral density in patients with sarcoidosis: a 4-year follow-up study. Osteoporos Int (2008) 0.85
The methylglyoxal-derived AGE tetrahydropyrimidine is increased in plasma of individuals with type 1 diabetes mellitus and in atherosclerotic lesions and is associated with sVCAM-1. Diabetologia (2013) 0.85
Cardiometabolic treatment decisions in patients with type 2 diabetes: the role of repeated measurements and medication burden. Qual Saf Health Care (2010) 0.85
Plasma homocysteine is weakly correlated with plasma endothelin and von Willebrand factor but not with endothelium-dependent vasodilatation in healthy postmenopausal women. Clin Chem (1999) 0.84
Up-regulation of the complement system in subcutaneous adipocytes from nonobese, hypertriglyceridemic subjects is associated with adipocyte insulin resistance. J Clin Endocrinol Metab (2012) 0.84
Structural and enzymological properties of cellular phospholipases A2. Biochem Soc Trans (1990) 0.83
Increased Nepsilon-(carboxymethyl)-lysine levels in cerebral blood vessels of diabetic patients and in a (streptozotocin-treated) rat model of diabetes mellitus. Eur J Endocrinol (2008) 0.83
Prevalence of diabetes mellitus in patients with acromegaly. Endocr Connect (2014) 0.82
CETP inhibition in cardiovascular risk management: a critical appraisal. Eur J Clin Invest (2007) 0.82
Amadori albumin and advanced glycation end-product formation in peritoneal dialysis using icodextrin. Perit Dial Int (2001) 0.82
Higher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12 year follow-up study. Diabetologia (2012) 0.82
Unhealthy dietary patterns associated with inflammation and endothelial dysfunction in type 1 diabetes: the EURODIAB study. Nutr Metab Cardiovasc Dis (2012) 0.82
BclI glucocorticoid receptor polymorphism is associated with greater body fatness: the Hoorn and CODAM studies. J Clin Endocrinol Metab (2013) 0.81
Levels and localization of group II phospholipase A2 and annexin I in interleukin- and dexamethasone-treated rat mesangial cells: evidence against annexin mediation of the dexamethasone-induced inhibition of group II phospholipases A2. Biochim Biophys Acta (1994) 0.81
Early glycated albumin, but not advanced glycated albumin, methylglyoxal, or 3-deoxyglucosone increases the expression of PAI-1 in human peritoneal mesothelial cells. Perit Dial Int (2001) 0.80
Modulation of plasma endothelin levels by the menstrual cycle. Metabolism (2000) 0.79
Angiotensin II blockade is associated with decreased plasma leukocyte adhesion molecule levels in diabetic nephropathy. Diabetes Care (2000) 0.79
Do diabetologists recognise self-management problems in their patients? Diabetes Res Clin Pract (2004) 0.79
Aberration in de novo ether lipid biosynthesis in peroxisomal disorders. Prog Clin Biol Res (1988) 0.79
Tissue factor pathway inhibitor (TFPI) release after heparin stimulation is increased in Type 1 diabetic patients with albuminuria. Diabet Med (2003) 0.78
Short-term hormone replacement therapy: reduced plasma levels of soluble adhesion molecules. Eur J Clin Invest (1999) 0.78
Associations of advanced glycation end-products with cognitive functions in individuals with and without type 2 diabetes: the maastricht study. J Clin Endocrinol Metab (2014) 0.78
Effects of dexamethasone and transforming growth factor-beta 2 on group II phospholipase A2 mRNA and activity levels in interleukin 1 beta- and forskolin-stimulated mesangial cells. Biochem J (1996) 0.77
Plasma adiponectin is modestly decreased during 24-hour insulin infusion but not after inhibition of lipolysis by Acipimox. Scand J Clin Lab Invest (2005) 0.77
The ability of plasma to stimulate fibroblast cholesterol efflux is associated with the -629C-->A cholesteryl ester transfer protein promoter polymorphism: role of lecithin: cholesterol acyltransferase activity. Biochim Biophys Acta (2007) 0.76
Cyclical Cushing's syndrome due to an atypical thymic carcinoid. Neth J Med (2006) 0.76
Effects of transdermal and oral oestrogen replacement therapy on C-reactive protein levels in postmenopausal women: a randomised, placebo-controlled trial. Thromb Haemost (2002) 0.76
Distinct associations of HbA1c and the urinary excretion of pentosidine, an advanced glycosylation end-product, with markers of endothelial function in insulin-dependent diabetes mellitus. Thromb Haemost (1998) 0.76
Deriving reference values and utilities for the QoL-AGHDA in adult GHD. Eur J Health Econ (2010) 0.75
Time to move from serum creatinine to eGFR. Diabet Med (2007) 0.75
[Doubts as to the cardiovascular safety of rosiglitazone]. Ned Tijdschr Geneeskd (2007) 0.75
Is AGE accumulation a therapeutic target for diabetic complications? Neth J Med (2006) 0.75
Intestinal pseudo-obstruction as a complication of paragangliomas: case report and literature review. Neth J Med (2013) 0.75
Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women. Fertil Steril (1999) 0.75
The combination of insulin and GLP-1 analogues in the treatment of type 2 diabetes. Neth J Med (2012) 0.75
[Long-term follow-up is indicated after surgery for a phaeochromocytoma]. Ned Tijdschr Geneeskd (2006) 0.75
An unusual cause of hyperandrogenism. Neth J Med (2012) 0.75
Raloxifene, conjugated oestrogen and endothelial function in postmenopausal women. J Intern Med (2003) 0.75
The increase in plasma levels of Nepsilon-(carboxymethyl)lysine during icodextrin treatment of peritoneal dialysis patients is not associated with increased plasma levels of vascular cell adhesion molecule-1. Perit Dial Int (2006) 0.75
[Missed hyperinsulinaemia in a patient with an insulinoma]. Ned Tijdschr Geneeskd (2005) 0.75
[Hypocortisolism associated with nephrotic syndrome]. Ned Tijdschr Geneeskd (2017) 0.75
Prevention of the induced synthesis and secretion of group II phospholipase A2 by brefeldin A. FEBS Lett (1993) 0.75
No increase in C-reactive protein levels during intranasal compared to oral hormone therapy in healthy post-menopausal women. Hum Reprod (2006) 0.75
Risk stratification for healthcare planning in women with gestational diabetes mellitus. Neth J Med (2016) 0.75
The current total economic burden of diabetes mellitus in the Netherlands. Neth J Med (2017) 0.75
5D.06: EFFECTS OF SODIUM AND POTASSIUM SUPPLEMENTATION ON ENDOTHELIAL FUNCTION AND INFLAMMATION IN UNTREATED (PRE)HYPERTENSIVES: A FULLY CONTROLLED DIETARY INTERVENTION STUDY. J Hypertens (2015) 0.75
Purification and characterization of Ca(2+)-dependent phospholipases A2 from rat kidney. Arch Biochem Biophys (1996) 0.75